Caregiver Profile

Caregiver Profile

Meet Dr. Mary Mullen

EDUCATION

Undergraduate Degree

  • Harvard College , 1983 , Cambridge , MA

Medical School

  • Harvard Medical School , 1991 , Boston , MA

Internship

  • Massachusetts General Hospital , 1992 , Boston , MA

Residency

  • Massachusetts General Hospital , 1997 , Boston , MA

Fellowship

  • Boston Children's Hospital , 1999 , Boston , MA

Fellowship

  • Massachusetts General Hospital , 1999 , Boston , MA

CERTIFICATIONS

  • American Board of Internal Medicine
  • American Board of Internal Medicine, Adult Congenital Heart Disease
  • American Board of Pediatrics, Pediatric Cardiology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020944858. View abstract
  2. Long-Term Fate of the Truncal Valve. J Am Heart Assoc. 2020 11 17; 9(22):e019104. View abstract
  3. Prenatal duct closure leading to severe pulmonary hypertension in a preterm neonate-a case report. Cardiovasc Diagn Ther. 2020 Oct; 10(5):1691-1695. View abstract
  4. Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol. 2020 07; 76(1):94-100. View abstract
  5. Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. J Am Med Inform Assoc. 2020 02 01; 27(2):294-300. View abstract
  6. Longitudinal Analysis of Ventilation Perfusion Mismatch in Congenital Diaphragmatic Hernia Survivors. J Pediatr. 2020 04; 219:160-166.e2. View abstract
  7. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur Respir J. 2019 08; 54(2). View abstract
  8. Standardized outcomes in reproductive cardiovascular care: The STORCC initiative. Am Heart J. 2019 11; 217:112-120. View abstract
  9. Improving Safety of Intravenous Prostacyclin Administration to Pediatric Patients With Pulmonary Hypertension. Crit Care Nurse. 2019 Aug; 39(4):e1-e7. View abstract
  10. Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension. Pulm Circ. 2019 Jul-Sep; 9(3):2045894019856471. View abstract
  11. Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry. J Pediatr. 2019 08; 211:63-71.e6. View abstract
  12. Feature extraction for phenotyping from semantic and knowledge resources. J Biomed Inform. 2019 03; 91:103122. View abstract
  13. Pulmonary Artery Banding in Post-tricuspid Congenital Cardiac Shunting Defects with High Pulmonary Vascular Resistance. Pediatr Cardiol. 2019 Apr; 40(4):719-725. View abstract
  14. The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension. J Pediatr. 2018 06; 197:17-22. View abstract
  15. Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia. J Pediatr. 2017 09; 188:24-34.e1. View abstract
  16. A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry. J Pediatr. 2017 09; 188:224-231.e5. View abstract
  17. Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension. Circ Res. 2017 Aug 04; 121(4):341-353. View abstract
  18. Hepatic MDR3 expression impacts lipid homeostasis and susceptibility to inflammatory bile duct obstruction in neonates. Pediatr Res. 2017 07; 82(1):122-132. View abstract
  19. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr. 2016 Mar; 170:312-4. View abstract
  20. Identification, Prevention, and Management of Childhood Overweight and Obesity in a Pediatric Primary Care Center. Clin Pediatr (Phila). 2016 08; 55(9):860-6. View abstract
  21. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24; 132(21):2037-99. View abstract
  22. Lung Pathology in Pediatric Pulmonary Vein Stenosis. Pediatr Dev Pathol. 2016 May-Jun; 19(3):219-29. View abstract
  23. Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension. Pulm Circ. 2015 Jun; 5(2):322-326. View abstract
  24. Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. BMC Genomics. 2014 Dec 17; 15:1127. View abstract
  25. Response. Chest. 2014 Jun; 145(6):1439. View abstract
  26. Quality of life and parental adjustment in pediatric pulmonary hypertension. Chest. 2014 Feb; 145(2):237-244. View abstract
  27. Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child. Pediatrics. 2013 Dec; 132(6):e1699-703. View abstract
  28. Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Int J Cardiol. 2013 Oct 03; 168(3):2435-40. View abstract
  29. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7. View abstract
  30. Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med. 2013 Jan; 14(1):37-43. View abstract
  31. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Am J Respir Crit Care Med. 2013 Mar 15; 187(6):572-5. View abstract
  32. Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient. Pediatr Transplant. 2012 Dec; 16(8):E364-7. View abstract
  33. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. Int J Cardiol. 2013 Mar 20; 164(1):106-10. View abstract
  34. Pulmonary arterial hypertension: what the large pulmonary arteries tell us. Pediatr Cardiol. 2011 Aug; 32(6):759-65. View abstract
  35. Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it? J Pediatr. 2010 Aug; 157(2):186-90. View abstract
  36. Diagnostic strategies for acute presentation of pulmonary hypertension in children: particular focus on use of echocardiography, cardiac catheterization, magnetic resonance imaging, chest computed tomography, and lung biopsy. Pediatr Crit Care Med. 2010 Mar; 11(2 Suppl):S23-6. View abstract
  37. Lung abscess in adults with tetralogy of fallot and pulmonary atresia. Cardiol Young. 2010 Feb; 20(1):91-3. View abstract
  38. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. Arch Dis Child. 2009 Jul; 94(7):506-11. View abstract
  39. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population. Anesth Analg. 2008 Aug; 107(2):371-8. View abstract
  40. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007 Dec; 120(6):1260-9. View abstract
  41. Cardiovascular malformations in Fryns syndrome: is there a pathogenic role for neural crest cells? . 2005 Dec 15; 139(3):186-93. View abstract
  42. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000 Dec 07; 343(23):1688-96. View abstract
  43. Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992 Sep; 102(3):797-801. View abstract
  44. Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev. 1991 Apr; 5(4):642-55. View abstract
  45. Pleural Pneumocystis carinii infection. Chest. 1991 Mar; 99(3):774-6. View abstract
  46. Spontaneous pneumothoraces in AIDS patients receiving aerosolized pentamidine. Chest. 1988 Dec; 94(6):1317-8. View abstract